Literature DB >> 15848626

Changes in serum levels of growth factors in healthy individuals after living related liver donation.

E A Efimova1, M Glanemann, A K Nussler, G Schumacher, U Settmacher, S Jonas, N Nussler, P Neuhaus.   

Abstract

INTRODUCTION: To obtain better insight into the kinetics of hepatic growth factors following partial hepatectomy for living related liver donation, we investigated the postoperative changes in serum levels of hepatocyte growth factor (HGF), epidermal growth factor (EGF), vascular epidermal growth factor (VEGF), and transforming growth factor-alpha (TGF-alpha). PATIENTS AND METHODS: Eighteen healthy donors undergoing right hepatectomy for living related donation were enrolled in this study. Serum levels of HGF, EGF, VEGF, and TGF-alpha were measured using enzyme-linked immunosorbent assay kits before surgery, at 2 hours after resection, and daily during 5 days postoperatively.
RESULTS: Mean preoperative HGF serum levels in healthy adults were 778 +/- 64 pg/mL. Within 2 hours after operation, they significantly increased to 9608 +/- 3111 pg/mL afterward decreasing to 2726 +/- 241 at day 1 and 2283 +/- 250 pg/mL at day 2. Hereafter HGF serum levels stabilized at increased levels until day 5 (2109 +/- 138, 2047 +/- 219, 2283 +/- 336 pg/mL, respectively). At all time points, the differences between pre- and postoperative HGF levels were significant (P < .01). In contrast, VEGF and EGF serum levels showed no significant differences between pre- and postoperative levels at all time points. TGF-alpha was not detected using a commercially available test with a detection limit of 10 ng/mL, suggesting only low TGF-alpha serum levels following liver resection.
CONCLUSION: Significantly increased HGF serum levels after hepatectomy demonstrate its crucial role among the other investigated growth factors in regeneration of the remnant liver tissue during the early period after the operation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848626     DOI: 10.1016/j.transproceed.2004.12.170

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

1.  Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.

Authors:  Norimasa Miura; Hiroko Kabashima; Mika Shimizu; Reina Sato; Tomoe Tsukamoto; Tomomi Harada; Shunsaku Takahashi; Ryujin Endo; Nobuaki Nakayama; Yasuhiro Takikawa; Satoshi Mochida; Kazuyuki Suzuki; Junichi Hasegawa; Goshi Shiota
Journal:  Hepatol Int       Date:  2008-04-09       Impact factor: 6.047

2.  Influence of cytokines, circulating markers and growth factors on liver regeneration and post-hepatectomy liver failure: a systematic review and meta-analysis.

Authors:  Anastasia Murtha-Lemekhova; Juri Fuchs; Omid Ghamarnejad; Mohammedsadegh Nikdad; Pascal Probst; Katrin Hoffmann
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

3.  Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity.

Authors:  Matthew M Cousins; Theresa P Devasia; Christopher M Maurino; Justin Mikell; Matthew J Schipper; Ravi K Kaza; Theodore S Lawrence; Kyle C Cuneo; Yuni K Dewaraja
Journal:  J Nucl Med       Date:  2021-09-09       Impact factor: 11.082

4.  Markers of angiogenesis associated with surgical attenuation of congenital portosystemic shunts in dogs.

Authors:  M S Tivers; A K House; K C Smith; C P D Wheeler-Jones; V J Lipscomb
Journal:  J Vet Intern Med       Date:  2014-08-08       Impact factor: 3.333

5.  Mechanistic Modelling of Drug-Induced Liver Injury: Investigating the Role of Innate Immune Responses.

Authors:  Lisl Km Shoda; Christina Battista; Scott Q Siler; David S Pisetsky; Paul B Watkins; Brett A Howell
Journal:  Gene Regul Syst Bio       Date:  2017-05-30

6.  Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver Injury.

Authors:  Kyle C Cuneo; Theresa Devasia; Yilun Sun; Matthew J Schipper; David Karnak; Mary A Davis; Dawn Owen; Mary Feng; Issam El Naqa; Latifa Bazzi; Randy Ten Haken; Theodore S Lawrence
Journal:  Transl Oncol       Date:  2019-05-09       Impact factor: 4.243

7.  Markers of liver regeneration-the role of growth factors and cytokines: a systematic review.

Authors:  Katrin Hoffmann; Alexander Johannes Nagel; Kazukata Tanabe; Juri Fuchs; Karolin Dehlke; Omid Ghamarnejad; Anastasia Lemekhova; Arianeb Mehrabi
Journal:  BMC Surg       Date:  2020-02-12       Impact factor: 2.102

Review 8.  HGF/c-Met: A Key Promoter in Liver Regeneration.

Authors:  Yang Zhao; Wenling Ye; Yan-Dong Wang; Wei-Dong Chen
Journal:  Front Pharmacol       Date:  2022-03-17       Impact factor: 5.810

9.  Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma.

Authors:  Y Lemos-González; F J Rodríguez-Berrocal; O J Cordero; C Gómez; M Páez de la Cadena
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640

10.  Serial changes of serum growth factor levels and liver regeneration after partial hepatectomy in healthy humans.

Authors:  Kazuyuki Matsumoto; Yasuhiro Miyake; Yuzo Umeda; Hiroshi Matsushita; Hiroaki Matsuda; Akinobu Takaki; Hiroshi Sadamori; Kazuhiro Nouso; Takahito Yagi; Toshiyoshi Fujiwara; Kazuhide Yamamoto
Journal:  Int J Mol Sci       Date:  2013-10-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.